Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
XtalPi leverages artificial intelligence, quantum physics, and robotics to accelerate drug discovery and development. Its ID4 and Hybrid AI + QM platforms enable pharmaceutical companies to identify promising compounds more efficiently. The company has demonstrated success in automating laboratory workflows ("self-driving labs") and recently expanded into biologics with the launch of its Ailux platform. It primarily operates as a technology/platform provider rather than developing its own clinical pipeline assets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on XtalPi.